Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh has invited applications for admission to the M.Sc./M.Sc MLT Courses, January 2022 session./
Programs: Master of Science Courses: Pharmacology, Master of Audiology & Speech Language Pathology, Respiratory Care (sponsored candidates only), Anaesthesia (sponsored candidates only).
M.Sc MLT Courses (For Sponsored/Deputed Candidates Only): M.Sc. Medical Laboratory Technology (i) Cytopathology (ii) Immunopathology (iii) Bacteriology & Mycology (iv) Virology (v) Biotechnology (vi) Haematology (vii) Parasitology (viii) Pharmacology; M.Sc. Medical Technology Radiotherapy; M.Sc. Medical Technology Radiodiagnosis.
Eligibility for non-sponsored seats: M.Sc. (Pharmacology): MBBS passed or its equivalent qualification or B.Sc (Anatomy, Physiology and Biochemistry taken together) or B.V.Sc. Or B. Pharma passed.
Master of Audiology & Speech Language Pathology (MASLP): B.Sc. (Audiology & Speech Therapy) or Bachelor of Audiology & Speech Language Pathology with at least 50% marks and one-year Internship after obtaining the qualification of B.Sc.
Eligibility for admission to other Courses are available in the Prospectus that can be downloaded from https://pgimer.edu.in/ (Information to candidates link)
Selection to all Programs will be based on a Computer Based Test to be held on 26.11.2021 at Chandigarh, New Delhi & Mohali(Punjab). Details are given in the Prospectus.
Online registration can be done at www.pgimer.edu.in latest by 12.11.2021.
Application and Examination Fee is Rs.1200/- for SC/ST Category and Rs. 1500/- for General /OBC/Sponsored Category. Persons with Bench-mark Disabilities (PwBD) Candidates are exempted from payment of fee.
Applicants may pay the fees online through payment gateway using Debit / Credit Card / Net Banking, latest by 12.11.2021.
Tuition fee per annum for all courses will be Rs. 350/-
For more information, visit www.pgimer.edu.in
Published: 08 Nov 2021, 05:21 am IST
Related Topics
Subscribe to our Newsletter
Get Latest Mathrubhumi Updates in English
Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.

